IBDEI14B ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,18136,0)
;;=E10.610^^61^804^9
;;^UTILITY(U,$J,358.3,18136,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18136,1,3,0)
;;=3^DM Type 1 w/ Diab Neuropathic Arthropathy
;;^UTILITY(U,$J,358.3,18136,1,4,0)
;;=4^E10.610
;;^UTILITY(U,$J,358.3,18136,2)
;;=^5002613
;;^UTILITY(U,$J,358.3,18137,0)
;;=E10.618^^61^804^23
;;^UTILITY(U,$J,358.3,18137,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18137,1,3,0)
;;=3^DM Type 1 w/ Oth Diab Arthropathy
;;^UTILITY(U,$J,358.3,18137,1,4,0)
;;=4^E10.618
;;^UTILITY(U,$J,358.3,18137,2)
;;=^5002614
;;^UTILITY(U,$J,358.3,18138,0)
;;=E10.630^^61^804^30
;;^UTILITY(U,$J,358.3,18138,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18138,1,3,0)
;;=3^DM Type 1 w/ Peridontal Disease
;;^UTILITY(U,$J,358.3,18138,1,4,0)
;;=4^E10.630
;;^UTILITY(U,$J,358.3,18138,2)
;;=^5002619
;;^UTILITY(U,$J,358.3,18139,0)
;;=E10.638^^61^804^27
;;^UTILITY(U,$J,358.3,18139,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18139,1,3,0)
;;=3^DM Type 1 w/ Oth Oral Compl
;;^UTILITY(U,$J,358.3,18139,1,4,0)
;;=4^E10.638
;;^UTILITY(U,$J,358.3,18139,2)
;;=^5002620
;;^UTILITY(U,$J,358.3,18140,0)
;;=E10.641^^61^804^15
;;^UTILITY(U,$J,358.3,18140,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18140,1,3,0)
;;=3^DM Type 1 w/ Hypoglycemia w/ Coma
;;^UTILITY(U,$J,358.3,18140,1,4,0)
;;=4^E10.641
;;^UTILITY(U,$J,358.3,18140,2)
;;=^5002621
;;^UTILITY(U,$J,358.3,18141,0)
;;=E10.649^^61^804^16
;;^UTILITY(U,$J,358.3,18141,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18141,1,3,0)
;;=3^DM Type 1 w/ Hypoglycemia w/o Coma
;;^UTILITY(U,$J,358.3,18141,1,4,0)
;;=4^E10.649
;;^UTILITY(U,$J,358.3,18141,2)
;;=^5002622
;;^UTILITY(U,$J,358.3,18142,0)
;;=E10.65^^61^804^14
;;^UTILITY(U,$J,358.3,18142,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18142,1,3,0)
;;=3^DM Type 1 w/ Hyperglycemia
;;^UTILITY(U,$J,358.3,18142,1,4,0)
;;=4^E10.65
;;^UTILITY(U,$J,358.3,18142,2)
;;=^5002623
;;^UTILITY(U,$J,358.3,18143,0)
;;=E10.69^^61^804^29
;;^UTILITY(U,$J,358.3,18143,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18143,1,3,0)
;;=3^DM Type 1 w/ Oth Spec Compl
;;^UTILITY(U,$J,358.3,18143,1,4,0)
;;=4^E10.69
;;^UTILITY(U,$J,358.3,18143,2)
;;=^5002624
;;^UTILITY(U,$J,358.3,18144,0)
;;=E10.8^^61^804^33
;;^UTILITY(U,$J,358.3,18144,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18144,1,3,0)
;;=3^DM Type 1 w/ Unspec Compl
;;^UTILITY(U,$J,358.3,18144,1,4,0)
;;=4^E10.8
;;^UTILITY(U,$J,358.3,18144,2)
;;=^5002625
;;^UTILITY(U,$J,358.3,18145,0)
;;=E10.9^^61^804^34
;;^UTILITY(U,$J,358.3,18145,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18145,1,3,0)
;;=3^DM Type 1 w/o Compl
;;^UTILITY(U,$J,358.3,18145,1,4,0)
;;=4^E10.9
;;^UTILITY(U,$J,358.3,18145,2)
;;=^5002626
;;^UTILITY(U,$J,358.3,18146,0)
;;=E10.620^^61^804^5
;;^UTILITY(U,$J,358.3,18146,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18146,1,3,0)
;;=3^DM Type 1 w/ Diab Dermatitis
;;^UTILITY(U,$J,358.3,18146,1,4,0)
;;=4^E10.620
;;^UTILITY(U,$J,358.3,18146,2)
;;=^5002615
;;^UTILITY(U,$J,358.3,18147,0)
;;=E10.36^^61^804^4
;;^UTILITY(U,$J,358.3,18147,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18147,1,3,0)
;;=3^DM Type 1 w/ Diab Cataract
;;^UTILITY(U,$J,358.3,18147,1,4,0)
;;=4^E10.36
;;^UTILITY(U,$J,358.3,18147,2)
;;=^5002602
;;^UTILITY(U,$J,358.3,18148,0)
;;=E10.621^^61^804^6
;;^UTILITY(U,$J,358.3,18148,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI14B 3759 printed Apr 09, 2024@21:44:37 Page 2
IBDEI14B ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,18136,0)
+2 ;;=E10.610^^61^804^9
+3 ;;^UTILITY(U,$J,358.3,18136,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,18136,1,3,0)
+6 ;;=3^DM Type 1 w/ Diab Neuropathic Arthropathy
+7 ;;^UTILITY(U,$J,358.3,18136,1,4,0)
+8 ;;=4^E10.610
+9 ;;^UTILITY(U,$J,358.3,18136,2)
+10 ;;=^5002613
+11 ;;^UTILITY(U,$J,358.3,18137,0)
+12 ;;=E10.618^^61^804^23
+13 ;;^UTILITY(U,$J,358.3,18137,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,18137,1,3,0)
+16 ;;=3^DM Type 1 w/ Oth Diab Arthropathy
+17 ;;^UTILITY(U,$J,358.3,18137,1,4,0)
+18 ;;=4^E10.618
+19 ;;^UTILITY(U,$J,358.3,18137,2)
+20 ;;=^5002614
+21 ;;^UTILITY(U,$J,358.3,18138,0)
+22 ;;=E10.630^^61^804^30
+23 ;;^UTILITY(U,$J,358.3,18138,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,18138,1,3,0)
+26 ;;=3^DM Type 1 w/ Peridontal Disease
+27 ;;^UTILITY(U,$J,358.3,18138,1,4,0)
+28 ;;=4^E10.630
+29 ;;^UTILITY(U,$J,358.3,18138,2)
+30 ;;=^5002619
+31 ;;^UTILITY(U,$J,358.3,18139,0)
+32 ;;=E10.638^^61^804^27
+33 ;;^UTILITY(U,$J,358.3,18139,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,18139,1,3,0)
+36 ;;=3^DM Type 1 w/ Oth Oral Compl
+37 ;;^UTILITY(U,$J,358.3,18139,1,4,0)
+38 ;;=4^E10.638
+39 ;;^UTILITY(U,$J,358.3,18139,2)
+40 ;;=^5002620
+41 ;;^UTILITY(U,$J,358.3,18140,0)
+42 ;;=E10.641^^61^804^15
+43 ;;^UTILITY(U,$J,358.3,18140,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,18140,1,3,0)
+46 ;;=3^DM Type 1 w/ Hypoglycemia w/ Coma
+47 ;;^UTILITY(U,$J,358.3,18140,1,4,0)
+48 ;;=4^E10.641
+49 ;;^UTILITY(U,$J,358.3,18140,2)
+50 ;;=^5002621
+51 ;;^UTILITY(U,$J,358.3,18141,0)
+52 ;;=E10.649^^61^804^16
+53 ;;^UTILITY(U,$J,358.3,18141,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,18141,1,3,0)
+56 ;;=3^DM Type 1 w/ Hypoglycemia w/o Coma
+57 ;;^UTILITY(U,$J,358.3,18141,1,4,0)
+58 ;;=4^E10.649
+59 ;;^UTILITY(U,$J,358.3,18141,2)
+60 ;;=^5002622
+61 ;;^UTILITY(U,$J,358.3,18142,0)
+62 ;;=E10.65^^61^804^14
+63 ;;^UTILITY(U,$J,358.3,18142,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,18142,1,3,0)
+66 ;;=3^DM Type 1 w/ Hyperglycemia
+67 ;;^UTILITY(U,$J,358.3,18142,1,4,0)
+68 ;;=4^E10.65
+69 ;;^UTILITY(U,$J,358.3,18142,2)
+70 ;;=^5002623
+71 ;;^UTILITY(U,$J,358.3,18143,0)
+72 ;;=E10.69^^61^804^29
+73 ;;^UTILITY(U,$J,358.3,18143,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,18143,1,3,0)
+76 ;;=3^DM Type 1 w/ Oth Spec Compl
+77 ;;^UTILITY(U,$J,358.3,18143,1,4,0)
+78 ;;=4^E10.69
+79 ;;^UTILITY(U,$J,358.3,18143,2)
+80 ;;=^5002624
+81 ;;^UTILITY(U,$J,358.3,18144,0)
+82 ;;=E10.8^^61^804^33
+83 ;;^UTILITY(U,$J,358.3,18144,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,18144,1,3,0)
+86 ;;=3^DM Type 1 w/ Unspec Compl
+87 ;;^UTILITY(U,$J,358.3,18144,1,4,0)
+88 ;;=4^E10.8
+89 ;;^UTILITY(U,$J,358.3,18144,2)
+90 ;;=^5002625
+91 ;;^UTILITY(U,$J,358.3,18145,0)
+92 ;;=E10.9^^61^804^34
+93 ;;^UTILITY(U,$J,358.3,18145,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,18145,1,3,0)
+96 ;;=3^DM Type 1 w/o Compl
+97 ;;^UTILITY(U,$J,358.3,18145,1,4,0)
+98 ;;=4^E10.9
+99 ;;^UTILITY(U,$J,358.3,18145,2)
+100 ;;=^5002626
+101 ;;^UTILITY(U,$J,358.3,18146,0)
+102 ;;=E10.620^^61^804^5
+103 ;;^UTILITY(U,$J,358.3,18146,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,18146,1,3,0)
+106 ;;=3^DM Type 1 w/ Diab Dermatitis
+107 ;;^UTILITY(U,$J,358.3,18146,1,4,0)
+108 ;;=4^E10.620
+109 ;;^UTILITY(U,$J,358.3,18146,2)
+110 ;;=^5002615
+111 ;;^UTILITY(U,$J,358.3,18147,0)
+112 ;;=E10.36^^61^804^4
+113 ;;^UTILITY(U,$J,358.3,18147,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,18147,1,3,0)
+116 ;;=3^DM Type 1 w/ Diab Cataract
+117 ;;^UTILITY(U,$J,358.3,18147,1,4,0)
+118 ;;=4^E10.36
+119 ;;^UTILITY(U,$J,358.3,18147,2)
+120 ;;=^5002602
+121 ;;^UTILITY(U,$J,358.3,18148,0)
+122 ;;=E10.621^^61^804^6
+123 ;;^UTILITY(U,$J,358.3,18148,1,0)
+124 ;;=^358.31IA^4^2
